Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I
WP Hausdorff, J Bryant, PR Paradiso… - Clinical Infectious …, 2000 - academic.oup.com
We analyzed> 70 recent data sets to compare the serogroups causing invasive
pneumococcal disease (IPD) with those represented in conjugate vaccine formulations. Five …
pneumococcal disease (IPD) with those represented in conjugate vaccine formulations. Five …
[HTML][HTML] Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
DK Chen, A McGeer, JC de Azavedo… - New England Journal …, 1999 - Mass Medical Soc
Background Fluoroquinolones are now recommended for the treatment of respiratory tract
infections due to Streptococcus pneumoniae, particularly when the isolates are resistant to β …
infections due to Streptococcus pneumoniae, particularly when the isolates are resistant to β …
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
WHB Demczuk, I Martin, A Griffith… - Canadian journal of …, 2013 - cdnsciencepub.com
The introduction of the 7-valent pneumococcal vaccine (PCV7) in Canada was very effective
in reducing invasive pneumococcal disease (IPD) in children; however, increases of non …
in reducing invasive pneumococcal disease (IPD) in children; however, increases of non …
Streptococcus pneumoniae infection: a Canadian perspective
Streptococcus pneumoniae infections have resulted in significant morbidity and mortality
worldwide in children and adults. In Canada, Streptococcus pneumoniae remains one of the …
worldwide in children and adults. In Canada, Streptococcus pneumoniae remains one of the …
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020
MA Alford, JA Karlowsky, HJ Adam… - Journal of …, 2023 - academic.oup.com
Objectives To assess the antimicrobial susceptibility of 14 138 invasive Streptococcus
pneumoniae isolates collected in Canada from 2011 to 2020. Methods Antimicrobial …
pneumoniae isolates collected in Canada from 2011 to 2020. Methods Antimicrobial …
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007
JA Bettinger, DW Scheifele, JD Kellner, SA Halperin… - Vaccine, 2010 - Elsevier
Active surveillance was conducted by the 12 centers of the Canadian Immunization
Monitoring Program, Active from 2000–2007 in children 16 years of age and younger to …
Monitoring Program, Active from 2000–2007 in children 16 years of age and younger to …
Evolution of S treptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999
JL Di Fabio, E Castañeda, CI Agudelo… - The Pediatric …, 2001 - journals.lww.com
Background. Since 1993 the Pan American Health Organization has coordinated a
surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile …
surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile …
Antimicrobial Resistance in Respiratory Tract Streptococcus pneumoniae Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002
GG Zhanel, L Palatnick, KA Nichol… - Antimicrobial agents …, 2003 - Am Soc Microbiol
ABSTRACT A total of 6,991 unique patient isolates of Streptococcus pneumoniae were
collected from October 1997 to June 2002 from 25 medical centers in 9 of the 10 Canadian …
collected from October 1997 to June 2002 from 25 medical centers in 9 of the 10 Canadian …
Surveillance for Invasive Streptococcus pneumoniae Disease among Hospitalized Children in Bangladesh: Antimicrobial Susceptibility and Serotype Distribution
Background. Vaccines offer the prospect of primary disease prevention of pneumococcal
disease in childhood. For introduction of such vaccines in developing countries, information …
disease in childhood. For introduction of such vaccines in developing countries, information …
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections
(LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has …
(LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has …